Item 5.07. Submission of Matters to a Vote of Security Holders. OnMay 4, 2020 ,Neon Therapeutics, Inc. , aDelaware corporation ("Neon"), held a virtual special meeting of its stockholders (the "Special Meeting"). Neon's stockholders voted on Proposal 1 at the Special Meeting, which is described in more detail in the definitive proxy statement filed by Neon with theSecurities and Exchange Commission onApril 2, 2020 . Neon's stockholders were entitled to one vote for each share of common stock,$0.001 par value per share (each, a "Share"), held as of the close of business onMarch 23, 2020 (the "Record Date"). At the close of business on the Record Date, there were 28,931,978 Shares entitled to vote at the Special Meeting. Present at the Special Meeting or by proxy were holders of 20,363,853 Shares, representing 70.38% of the outstanding Shares eligible to vote at the Special Meeting, and constituting a quorum. The final results with respect to such proposal are set forth below. Proposal 1 - The Merger Proposal. To approve and adopt the Agreement and Plan of Merger, dated as ofJanuary 15, 2020 , or as amended, modified or otherwise supplemented from time to time (the "Merger Agreement"), by and among Neon,BioNTech SE , a Societas Europaea organized and existing under the laws ofGermany ("BioNTech"), andEndor Lights, Inc. , aDelaware corporation and a direct, wholly-owned subsidiary ofBioNTech : Votes For Votes Against Abstentions 19,696,223 73,646 593,984
Stockholder action on a second proposal, to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of approving the Merger Proposal, was not required and no vote was taken on that proposal. --------------------------------------------------------------------------------
2
--------------------------------------------------------------------------------
© Edgar Online, source